Penserra Capital Management LLC Innoviva, Inc. Transaction History

Penserra Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$15.91 - $18.72 $25,296 - $29,764	-1,590 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.06 - $17.24 $130 - $172	10 Added 0.63%	1,590 $26,000
Q2 2021 Aug 12, 2021	SELL	$11.45 - $13.96 $8,186 - $9,981	-715 Reduced 31.15%	1,580 $21,000
Q1 2021 May 13, 2021	SELL	$11.06 - $12.87 $884 - $1,029	-80 Reduced 3.37%	2,295 $27,000
Q4 2020 Feb 12, 2021	BUY	$9.33 - $12.48 $14,097 - $18,857	1,511 Added 174.88%	2,375 $29,000
Q3 2020 Nov 13, 2020	BUY	$10.33 - $14.49 $8,925 - $12,519	864 New	864 $9,000
Q1 2019 May 08, 2019	SELL	$13.69 - $20.06 $8.51 Million - $12.5 Million	-621,906 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$13.96 - $18.26 $8.68 Million - $11.4 Million	621,906 New	621,906 $10.9 Million

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.